Mylan
Executive Summary
In mid-May, FDA inspected the company's Morgantown, W. Va. plant for five days. The investigators conducted product-specific inspections on nine generic products and for sucralfate, which has an NDA pending. Mylan maintains all the products passed the inspection, including loperamide and cyclobenzaprine....